These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3535601)

  • 1. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke.
    Duke RJ; Bloch RF; Turpie AG; Trebilcock R; Bayer N
    Ann Intern Med; 1986 Dec; 105(6):825-8. PubMed ID: 3535601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
    Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind randomised trial of intravenous glycerol in acute stroke.
    Bayer AJ; Pathy MS; Newcombe R
    Lancet; 1987 Feb; 1(8530):405-8. PubMed ID: 2880214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous heparin for acute stroke: what can we learn from the megatrials?
    Swanson RA
    Neurology; 1999 Jun; 52(9):1746-50. PubMed ID: 10371518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute ischemic stroke. Open trial with continuous intravenous heparinization.
    Ramirez-Lassepas M; Quiñones MR; Nino HH
    Arch Neurol; 1986 Apr; 43(4):386-90. PubMed ID: 3513740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there still a role for intravenous heparin in acute stroke? No.
    Sandercock P
    Arch Neurol; 1999 Sep; 56(9):1160-1. PubMed ID: 10488820
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there still a role for intravenous heparin in acute stroke? Yes.
    Grau AJ; Hacke W
    Arch Neurol; 1999 Sep; 56(9):1159-60. PubMed ID: 10488819
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous heparin in acute stroke.
    Hachinski V
    Arch Neurol; 1999 Sep; 56(9):1162. PubMed ID: 10488821
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin, heparin, or both to treat acute unstable angina.
    Théroux P; Ouimet H; McCans J; Latour JG; Joly P; Lévy G; Pelletier E; Juneau M; Stasiak J; deGuise P
    N Engl J Med; 1988 Oct; 319(17):1105-11. PubMed ID: 3050522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin for the treatment of acute ischemic stroke.
    Kay R; Wong KS; Yu YL; Chan YW; Tsoi TH; Ahuja AT; Chan FL; Fong KY; Law CB; Wong A
    N Engl J Med; 1995 Dec; 333(24):1588-93. PubMed ID: 7477193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.
    Doyle DJ; Turpie AG; Hirsh J; Best C; Kinch D; Levine MN; Gent M
    Ann Intern Med; 1987 Oct; 107(4):441-5. PubMed ID: 3307582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions.
    Camerlingo M; Salvi P; Belloni G; Gamba T; Cesana BM; Mamoli A
    Stroke; 2005 Nov; 36(11):2415-20. PubMed ID: 16224085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind trial of glycerol therapy in early stroke.
    Larsson O; Marinovich N; Barber K
    Lancet; 1976 Apr; 1(7964):832-4. PubMed ID: 56650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke - pilot study.
    Dluha J; Sivak S; Kurca E; Dusenka R; Kalmarova K; Turcanova Koprusakova M; Kantorova E; Nosal V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):543-548. PubMed ID: 27646496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin in acute partial stable stroke.
    Ann Intern Med; 1987 May; 106(5):781-2. PubMed ID: 3565991
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.
    Sandercock PA; van den Belt AG; Lindley RI; Slattery J
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):17-25. PubMed ID: 8429318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
    Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
    JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial.
    Hsu CY; Faught RE; Furlan AJ; Coull BM; Huang DC; Hogan EL; Linet OI; Yatsu FM
    Stroke; 1987; 18(2):352-8. PubMed ID: 3551212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of heparin therapy: Controlled prospective trial.
    Salzman EW; Deykin D; Shapiro RM; Rosenberg R
    N Engl J Med; 1975 May; 292(20):1046-50. PubMed ID: 1091856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.